Guanhua Du

Hunan University of Science and Technology

Also affiliated with Academy of Medical Sciences, Target (United States), Tianjin University of Technology, Henan University, Shanghai Jiao Tong University, Chinese Academy of Medical Sciences & Peking Union Medical College, State Administration of Traditional Chinese Medicine of the People's Republic of China, West China Medical Center of Sichuan University, Peking Union Medical College Hospital, Shanghai Ninth People's Hospital, Xinjiang Institute of Materia Medica, Ministry of Education, Shanghai Institute of Materia Medica, Drug Discovery Laboratory (Norway), Marine Biomedical Research Institute of Qingdao, Ocean University of China, Academia Sinica

MedicineNeurosciencePharmacology, Toxicology and PharmaceuticsBiochemistry, Genetics and Molecular BiologyComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial”.

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

The Lancet(2020)10.1016/s0140-6736(20)31022-9

N/A

11.3DataRank · unranked

3663 citations

Dingyu Zhang, Guanhua Du, Ronghui Du, Jianping Zhao, Yang Jin +41 more